RxSight (RXST) CBO Eric Weinberg Exchanges Options

What Happened
Eric Weinberg, Chief Business Development Officer of RxSight (RXST), participated in the company's option exchange program on Sept 5, 2026. The Form 4 reports dispositions to the issuer of 449,637 option-equivalent shares (several outstanding option awards cancelled) and the grant/acquisition of 334,075 option-equivalent shares as replacement awards. The new post-exchange exercise price is $6.375 per share. These entries are derivative transactions (codes D for disposition to issuer and A for grant/acquisition) and do not represent open-market sales or cash received at the time of the exchange.

Key Details

• Transaction date: September 5, 2026; Form 4 filed September 9, 2026 (timely).
• Dispositions (old options cancelled): 87,437; 95,000; 92,200; 50,000; 125,000 — total 449,637.
• Acquisitions (new/options issued): 65,742; 82,608; 59,483; 32,258; 93,984 — total 334,075.
• Post-exchange exercise price for the new options: $6.375 per share. Reported prices are N/A because these are option exchanges, not open-market trades.
• Net change in derivative option-equivalents: decrease of 115,562 shares (449,637 cancelled vs. 334,075 issued).
• Shares owned after the transaction: not specified in the provided summary of the filing.
• Notable footnotes: multiple exchange ratios were applied to different option grants (e.g., 1.33:1, 1.15:1, 1.55:1 per footnotes), and many replacement options are subject to vesting conditions — monthly vesting schedules or 25% on Feb 28, 2027 with remaining vesting Aug 31, 2027, contingent on continued service.

Context
This was an option-exchange (reissuance) transaction — the insider did not sell shares on the market nor receive cash as part of these entries. The filing reflects restructuring of option awards (old options cancelled and new options issued with a $6.375 exercise price) and includes detailed vesting schedules; any future exercises or open-market sales would be reported separately on subsequent Form 4s. For retail investors, these adjustments are administrative and do not by themselves indicate a sale or buy signal.